arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ORTHOPEDIATRICS CORP

KIDS
$22.91 ▲ +0.03 (+0.13%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
41 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
27
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORTHOPEDIATRICS CORP faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $542.6M
Dividend Yield
Revenue Growth 13.3%
Op. Margin -14.0%
ROIC -1.8%
FCF / Share $-0.21
Trailing P/E
Price / Book 1.6x
FCF Yield
Debt / Equity 0.31
info Valuation on last close. End-of-day price, Aug 7, 2026.

41-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$59.36M
↑ +13.3%
Net Income Profit after all expenses
$-10.69M
— -0.3%
Operating Margin Operating profit as % of sales
-14.0%
↓ -5.8% 11th
FCF / Share Free cash flow per share
$-0.21
↑ +40.9%
Long-Term Debt Long-term obligations
$106.65M
↑ +0.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
12
Returns
33
Financial Health
33
Cash Quality
36

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 41 quarters